China Resources Pharma Increases Stake in Dong-E-E-Jiao

TipRanksDec 18 23:13

CHINARES PHARMA (03320) subsidiary CHINARES PHARMA Investment has cumulatively increased its Shareholding in Dong-E-E-Jiao by 1% of the share capital.

CHINARES PHARMA (03320) announced that from November 8, 2024, to December 18, 2024, this...

Zhitong FinanceDec 18 22:41

Express News | Dong-E-E-Jiao: The concerted parties of controlling Shareholder have increased their Shareholding in the company to 1% and plan to continue to increase their shareholding.

BreakingsDec 18 18:50

Zhongtai: The implementation of the tenth batch of centralized procurement is expected to accelerate the clearance of generic drugs. Commercial insurance is an important incremental logic in the pharmaceutical Sector.

It is recommended to keep a close eye on the progress and implementation of commercial insurance, as improvements in the payment sector are expected to bring about a significant market trend in the Pharmaceutical Sector, with opportunities for recovery and reversal in hospital pharmaceuticals, diagnostics, and Medical Devices.

Zhitong FinanceDec 16 14:45

Express News | Institutions are bullish on these stocks today.

BreakingsDec 13 22:20

Dong-E-E-Jiao (000423): "Pharmaceutical + Consumer health products" dual-drive rejuvenates the health supplement brand.

With quality as the foundation and a firm commitment to innovation, the first brand in health and nourishment, the predecessor of the company, ShanDong Dong-E-E-Jiao Factory, was established in 1952, and in 1993, ShanDong Dong-E-E-Jiao (Group) Co., Ltd. was formed. In 1996, it was listed on the Shenzhen Stock Exchange, and subsequently,

Open Source SecuritiesDec 13 15:52